Search Thermo Fisher Scientific
Comprehensive solutions to support cancer vaccine research from genomic biomarker tools to protein expression services
Cancer vaccines represent an important immuno-oncology research area aimed at enabling the immune system to recognize cancer as a threat (Figure 1). This method is antigen-based, relying on the ability of the immune system to recognize the protein to induce the immune response. Cancer vaccine research is rapidly evolving due to the potential behind combination therapies and personalized approaches. Thermo Fisher Scientific offers solutions to support cancer vaccine research from genomic biomarker discovery and verification to antibody production services.
Maximize protein yield with GeneOptimizer software that generates sequence variants with enhanced mRNA stability and translational efficiency. Get up to four-fold average yield for monoclonal antibodies and other proteins.
A robust, targeted next-generation sequencing (NGS) assay providing clinical researchers with an accurate quantification of somatic mutation counts to assess TMB
CytoScan HD Suite provides the broadest coverage and highest performance for detecting chromosomal aberrations
Use microarray-based whole-genome copy number assays to detect a wide variety of somatic copy number aberrations including ploidy and chromothripsis.
NGS based assays for the assessment of tumor mutational burden (TMB)
Leverage industry-leading gene synthesis services, optimized protein expression services, or outsource the entire process of protein and cell line production with GeneArt services.
Discover tools and reagents needed for protein engineering.
We offer quality Invitrogen immunoassays designed to help you easily quantify checkpoint protein biomarkers with confidence.
The Immuno-Oncology Product Resource Guide is an introduction to immuno-oncology research, covering key approaches such as CAR T-cell therapy research and solutions for each application area.
仅供科研使用,不可用于诊断目的。